ALB and intrahepatic cholangiocarcinoma: Although AAV8-TBG-Cre has the advantage of specificity for mature hepatocytes, AAV8-TBG-Cre cannot take the place of Alb-Cre due to short lasting time and multiple injections in TAA-induced ICC.